Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Dodecanoate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD known ✓ | Q03181 | 7/20 | 0.94 |
| ▸ | HDAC11 known ✓ | Q96DB2 | 5/20 | 0.94 |
| ▸ | MEN1 known ✓ | O00255 | 1/20 | 0.94 |
| ▸ | ESR1 known ✓ | P03372 | 1/20 | 0.94 |
| ▸ | PDE4A known ✓ | P27815 | 1/20 | 0.94 |
| ▸ | PDE3A known ✓ | Q14432 | 1/20 | 0.94 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.94 |
| ▸ | PPARG | P37231 | 7/20 | 0.94 |
| ▸ | PPARA | Q07869 | 7/20 | 0.94 |
| ▸ | TSHR | P16473 | 4/20 | 0.94 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.94 |
| ▸ | FABP4 | P15090 | 3/20 | 0.94 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.94 |
| ▸ | TLR2 | O60603 | 2/20 | 0.94 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.94 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.94 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.94 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.94 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.94 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.94 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Stearic Acid SCHEMBL4657422 | 1.00 | GPR84 (0.94) | GPR84PPARGPPARDPPARAHDAC11 | |
| Tridecanoate SCHEMBL29624615 | 1.00 | GPR84 (0.94) | GPR84PPARGPPARDPPARAHDAC11 | |
| Decanoic Acid SCHEMBL11297381 | 1.00 | GPR84 (0.94) | GPR84PPARGPPARDPPARAHDAC11 | |
| Palmitic Acid SCHEMBL3958653 | 1.00 | GPR84 (0.94) | GPR84PPARGPPARDPPARAHDAC11 | |
| Myristic Acid SCHEMBL1169126 | 1.00 | GPR84 (0.94) | GPR84PPARGPPARDPPARAHDAC11 | |
| Octanoic Acid SCHEMBL31619587 | 1.00 | GPR84 (0.94) | GPR84PPARGPPARDPPARAHDAC11 | |
| Heptanoate SCHEMBL8058964 | 1.00 | GPR84 (0.94) | GPR84PPARGPPARDPPARAHDAC11 | |
| Stearic Acid SCHEMBL717819 | 1.00 | GPR84 (0.94) | GPR84PPARGPPARDPPARAHDAC11 | |
| Behenic Acid SCHEMBL4967667 | 1.00 | GPR84 (0.94) | GPR84PPARGPPARDPPARAHDAC11 | |
| Heptanoate SCHEMBL27814676 | 1.00 | GPR84 (0.94) | GPR84PPARGPPARDPPARAHDAC11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 206 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115253391-A | High-temperature-resistant defoaming agent applied to sawdust white water and preparation method thereof | 浙江金励环保纸业有限公司 | 2022-11-01 | — | — | CN | claimed |
| CN-115209859-A | Composition for cosmetics | 莱雅公司 | 2022-10-18 | — | — | CN | claimed |
| CN-115003272-A | Composition for caring for keratin materials | 莱雅公司 | 2022-09-02 | — | — | CN | claimed |
| CN-112057904-B | Defoaming agent and production process and application thereof | 北京金隅水泥节能科技有限公司 | 2021-07-09 | — | — | CN | claimed |
| CN-112057904-A | Defoaming agent and production process and application thereof | 北京金隅水泥节能科技有限公司 | 2020-12-11 | — | — | CN | claimed |
| CN-108867041-A | A kind of short rayon fiber oiling agent and its application | 浙江皇马科技股份有限公司 | 2018-11-23 | — | — | CN | claimed |
| CN-106978275-A | A kind of non-water type vehicle cleaning detergent and preparation method thereof | 芜湖扬展新材料科技服务有限公司 | 2017-07-25 | — | — | CN | claimed |
| CN-104928933-B | Non-silicon oil carbon fiber protofilament oil agent | 中国石油化工股份有限公司 | 2017-05-17 | — | — | CN | claimed |
| CN-105064019-A | Nylon 6 short fiber spinning oil agent, preparation method and application thereof | ZHEJIANG HUANGMA TECH CO LTD | 2015-11-18 | — | — | CN | claimed |
| CN-104928933-A | Non-silicon oil carbon fiber protofilament oil agent | CHINA PETROLEUM & CHEMICAL | 2015-09-23 | — | — | CN | claimed |
| CN-101443038-B | Nicotine-carrier vaccine formulations | CYTOS BIOTECHNOLOGY AG | 2012-07-04 | — | — | CN | claimed |
| CN-101854912-A | Multi-phasic, nano-structured compositions containing a combination of a fibrate and a statin | NOVAVAX INC | 2010-10-06 | — | — | CN | claimed |
| CN-101674813-A | Multi-phasic pharmaceutical formulation of poorly water soluble drugs for reducing fed/fasted variability and improving oral bioavailability | NOVAVAX INC | 2010-03-17 | — | — | CN | claimed |
| CN-101646419-A | Method of preparing solid dosage forms of multi-phasic pharmaceutical compositions | NOVAVAX INC US | 2010-02-10 | — | — | CN | claimed |
| CN-101443038-A | Nicotine-carrier vaccine formulations | CYTOS BIOTECHNOLOGY AG (CH) | 2009-05-27 | — | — | CN | claimed |
| CN-100384468-C | L-methionine as a stabilizer for NESP/EPO in hsa-free formulations | KIRIN AMGEN INC (US) | 2008-04-30 | — | — | CN | claimed |
| CN-1553811-A | Human tissue urokinase type plasminogen activator formulation | ӡ�����Ƽ��ɷ�����˾ | 2004-12-08 | — | — | CN | claimed |
| CN-1140296-C | Magnetic medicine-carried conveying material and preparation method thereof | 山东大学 | 2004-03-03 | — | — | CN | claimed |
| CN-1319434-A | Magnetic medicine-carried conveying material and preparation method thereof | UNIV SHANDONG (CN) | 2001-10-31 | — | — | CN | claimed |
| CN-1300597-A | Composition for treating cancer by magnetic positioning and its preparing process | UNIV SHANDONG (CN) | 2001-06-27 | — | — | CN | claimed |